Sign in
Taking people in United StatesNo phase

Following people with epilepsy-dyskinesia syndromes over time

Collects health data and samples from people with a genetic epilepsy-dyskinesia diagnosis.

Key facts

Who runs it
Boston Children's Hospital
Where
Boston, United StatesSee the site
Trial code
Registry title
Registry and Natural History of Epilepsy-Dyskinesia Syndromes
Status
Recruiting
People taking part
700 people, planned
Started
1 Jun 2025
Expected to end
Jul 2030
Type of study
Observational
Record updated
17 August 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people with a genetic diagnosis of an epilepsy-dyskinesia syndrome. It collects health data and biological samples over time.

Age
0 Years to 30 Years
Sex
All sexes
Disease stage
Epilepsy-dyskinesia syndromes with a genetic diagnosis.
Biomarker or test result
At least one pathogenic or likely pathogenic variant in one of the listed genes of interest (for example SCN1A, STXBP1, CDKL5, GNAO1, ATP1A3) or other genes linked to epilepsy-dyskinesia syndromes.

Main reasons for not taking part

  • No pathogenic or likely pathogenic variant in the genes of interest

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • Having at least one pathogenic or likely pathogenic variant in one of the genes of interest:; AARS2, ADCY5, ALG13, AP3B2, AP4B1, AP4E1, AP4M1, AP4S1, ARX, ATP1A3, CACNA1A, CACNA1E, CACNA2D2, CDKL5, CSTB, DARS2, DLAT, DLD, DNM1, EARS2, EPG5, EPM2A, FARS2, FOXG1, FRRS1L, GABRA1, GABRA2, GABRB2, GABRB3, GABRG2, GNAO1, GRIA2, GRIA4, GRIN1, GRIN2A, GRIN2B, GRIN2D, HARS2, HNRNPU, HTT, IQSEC2, IRF2BPL, KCNA2, KCNB1, KCNC1, KCNMA1, KCNQ2, KCNQ3, KCNT1, LARS2, MECP2, MEF2C, MTND5, MTTK, MTTL1, NARS2, NHLRC1, PCDH12, PCDH19, PDE10A, PDE2, PDHA1, PDHB, PDHX, PDK3, PDP1, PIGA, PIGN, PIGP, PIGQ, PIGS, PLCB1, POLG, PRRT2, PURA, RHOBTB2, SCN1A, SCN1B, SCN2A, SCN8A, SCN9A, SETBP1, SETD5, SLC13A5, SLC1A2, SLC25A22, SLC2A1, SMC1A, SNX14, SPTAN1, ST3GAL3, STXBP1, SYNGAP1, SYNJ1, SZT2, TARS2, TBC1D24, UBA5, UBE3A, VAMP2, VARS2, WARS2, WDR45, WWOX, YIF1B, YWHAG, and other genes associated with epilepsy-dyskinesia syndromes

Who cannot take part

  • Not having a pathogenic or likely pathogenic variants in the genes of interest

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 0 and 30 years old?

Where in United States

  • Boston Children's HospitalBoston, United StatesContact: Darius Ebrahimi-Fakhari, MD, PhDTaking people

About the trial

What the trial wants to find out

The Registry and Natural History of Epilepsy-Dyskinesia Syndromes is focused on gathering longitudinal clinical data as well as biological samples (blood, urine, and/or skin/tissue) from male and female patients, of all ages, who have a genetic diagnosis of epilepsy-dyskinesia syndromes. Through prospective review and molecular data analysis, the study aims to identify patterns and correlations between movement and seizure disorders, uncovering genotype-phenotype relationships. The initiative's goals are to enhance understanding of epilepsy-dyskinesia syndromes, inform precision medicine approaches, and foster international collaboration.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Registry and Natural History of Epilepsy-Dyskinesia Syndromes
Plain-language title
Following people with epilepsy-dyskinesia syndromes over timeGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT06967727, who can take part
Record updated
17 August 2025